Biocon Ltd. | BIOCON | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
39,21641,29755,14463,67273,603
Cost of revenue
Cost of revenue
-14,771-16,424-18,966-20,522-22,085
Gross Profit
Gross Profit
24,445
24,873
36,178
43,150
51,518
Sales, general & ad...
Sales, general and administrative
-15,933-18,329-24,940-30,577-35,954
Depreciation
Depreciation and amortization
-2,772-3,851-4,478-5,522-7,151
Provision
Provision
002,69900
Other op inc/exp...
Other operating income/expenses
00003,507
Operating income
Operating income EBIT
5,740
2,693
9,459
7,051
11,920
 
      
Interest expense
Interest expense
-260-615-709-649-577
Other income/exp...
Other income(expense)
2,8543,8093,3905,747126
Profit before tax
Profit before tax
8,334
5,887
12,140
12,149
11,469
Income tax & other ta...
Income tax and other taxes
1,6161,5692,1233,1512,215
Net income from c...
Net income from continuing operations
6,7184,31810,0178,9989,254
Extraordinary & disc...
Extraordinary items & Discontinued Ops
0000-97
Share of associates
Share of associates
-7602139-289-695
Minority Interest
Minority Interest
163-807-973-1,227-1,057
Net Income
Net income
6,121
3,724
9,053
7,482
7,405
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
6,1213,7249,0537,4827,405
Basic shares
Basic shares
1,1781,1801,1831,1841,187
Diluted Shares
Diluted Shares
1,1861,1881,1911,1871,187
EPS Basic
EPS Basic in Rupees
5.203.167.656.326.24
EPS Diluted
EPS Diluted in Rupees
5.16
3.14
7.60
6.30
6.24